Search clinical trials for: Class II

Total 33930 results

Fundació Institut de Recerca de l'Hospital de la...
Carlos III Health Institute; Spanish Clinical Research Network - SCReN

Completed

Randomizated Open-label Control Trial to Evaluate if the Incorporation of sFlt1/PlGF Ratio in the Diagnosis and Classification of PE Improves Maternal and Perinatal Outcomes in Women With the Suspicion of the Disease (EuroPE)

Preeclampsia

Spain
Boston Scientific Corporation

Terminated

Step and Walking Pattern From Cardiac Monitor Study (SWAN)

Heart Failure NYHA Class II | Heart Failure NYHA Class III | Insertable Cardiac Monitor

United States
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)

Completed

Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma

Lymphoma | Metastatic Melanoma | Metastatic Renal Cell Cancer | Recurrent Renal Cell Carcinoma | Stage III Renal Cell Cancer | Stage IV Skin Melanoma | Stage IIIB Skin Melanoma | Stage IIIC Skin Melanoma | Stage III Bladder Cancer | Stage IV Bladder Cancer | Recurrent Lymphoma | Recurrent Malignant Solid Neoplasm and other conditions

United States
University of Leipzig

Active, not recruiting

Native T1 CMR Imaging for Diagnosis of Cardiac Amyloidosis (CMR for CA)

Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure With Preserved Ejection Fraction | Hypertrophy, Left Ventricular | Heart Failure NYHA Class IV | Cardiac Amyloidosis | Heart Failure With Mid Range Ejection Fraction

Germany
Bristol-Myers Squibb

Completed

Study of Nivolumab in Patients With Classical Hodgkin's Lymphoma (Registrational) (CheckMate 205)

Hodgkin Disease

Canada, United States, Belgium, Austria, Czechia, Germany, Italy, Netherlands, Spain, United Kingdom
University Ghent

Completed

Comparison of ACTIVA BioACTIVE Versus Compomer in Restoring Dental Decay in Primary Molar Teeth

Dental Caries in Children

Belgium
Jenny Kallunki
Region Östergötland; Malmö University; Eklund foundation Malmö; Swedish Dental...

Active, not recruiting

Treatment of Class II Malocclusion With Excessive Overjet

Quality of Life | Orthodontic Appliances | Class II Malocclusion, Division 1 | Costs and Cost Analysis

Sweden
Mansoura University

Completed

Clinical Performance of Dual- and Light-cure Bulk-fill Resin Composites

Dental Caries Class II

Egypt
Damascus University

Completed

The Effect of Platelet-rich Plasma on the Rate and Type of Orthodontic Tooth Movement

Class II Division 1 Malocclusion

Syrian Arab Republic
Sheffield Teaching Hospitals NHS Foundation Trust
Dentsply International

Completed

Clinical Study Class II on Ceram.x Universal and Prime&Bond

Dental Caries

United Kingdom
University of Baghdad

Active, not recruiting

Effectiveness of Modified Functional Appliance With Expander

Class II Malocclusion

Iraq
Nourhan M.Aly

Completed

Comparative Clinical Evaluation Between a Novel Self Adhesive and Conventional Bulk-fill Composites

Class II Dental Caries

Egypt
National Cancer Institute (NCI)

Active, not recruiting

Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer

HIV Infection | Hepatocellular Carcinoma | Non-Hodgkin Lymphoma | Metastatic Lung Non-Small Cell Carcinoma | Metastatic Melanoma | Kaposi Sarcoma | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Locally Advanced Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Unresectable... and other conditions

United States
David Bond, MD
Bristol-Myers Squibb

Active, not recruiting

Nivolumab With DA-REPOCH Chemotherapy Regimen in Treating Patients With Aggressive B-Cell Non-Hodgkin's Lymphoma

Diffuse Large B-Cell Lymphoma | Aggressive Non-Hodgkin Lymphoma | Indolent Non-Hodgkin Lymphoma | Ann Arbor Stage IV B-Cell Non-Hodgkin Lymphoma | High Grade B-Cell Lymphoma, Not Otherwise Specified | Transformed Non-Hodgkin Lymphoma | Ann Arbor Stage II B-Cell Non-Hodgkin Lymphoma | Ann Arbor Stage... and other conditions

United States
EMD Serono Research & Development Institute, Inc.
Merck KGaA, Darmstadt, Germany

Completed

Long-Term Outcomes and Durability of Effect Following Treatment With Cladribine Tablets for MS (CLASSIC-MS)

Multiple Sclerosis (MS)

United States, Lebanon, Spain, Sweden, Poland, Italy, Estonia, Australia, Austria, Belgium, Bulgaria, Canada, Croatia, Czechia, Finland, France, Georgia, Germany, Korea, Republic of, Lithuania, Norway, Portugal, Romania, Russian Federation and more
Damascus University

Completed

Pain and Discomfort in Two Acceleration Methods of Canine Retraction

Class II Malocclusion

Syrian Arab Republic
Cairo University

Completed

The Effect of Different Treatment Modalities of Class II Malocclusion on Upper Third Molars.

Third Molar Impaction

Egypt
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

Completed

An Open, Multicenter Phase II Study to Evaluate the Safety and Efficacy of KL-A167 Injection in Relapsed or Refractory Classical Hodgkin's Lymphoma

Classical Hodgkin Lymphoma

China
Pakistan Institute of Medical Sciences

Completed

Post-operative Sensitivity in Composite Restorations

Class II Dental Caries | Sensitivity, Tooth

Pakistan
University of Nebraska
National Cancer Institute (NCI)

Completed

Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer

Lymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Diseases | Graft Versus Host Disease | Secondary Myelofibrosis

United States
3M

Active, not recruiting

Scotchbond Universal Plus Compared to Scotchbond Universal for Posterior Class I & II Restorations With Filtek Universal

Cavities of Teeth | Dental Decay

United States
West Virginia University
National Institute of Nursing Research (NINR)

Completed

Family Palliative and End-of-Life Care for Advanced Heart Failure

Heart Failure NYHA Class III | Heart Failure NYHA Class IV

United States
Jennie Taylor
University of Minnesota

Active, not recruiting

Neo-adjuvant Evaluation of Glioma Lysate Vaccines in WHO Grade II Glioma

Glioma | Malignant Glioma | Oligodendroglioma | Astrocytoma, Grade II | Glioma, Astrocytic | Oligoastrocytoma, Mixed

United States
Fondazione per la Medicina Personalizzata

Active, not recruiting

The Rome Trial From Histology to Target: the Road to Personalize Target Therapy and Immunotherapy (ROME)

Breast Cancer | Non Small Cell Lung Cancer | Gastrointestinal Cancer | Other Cancer

Italy
Istanbul University

Completed

IL-10, IL-12 and IL-18 Levels in the Gingival Crevicular Fluid of Patients With Periodontitis and Healthy Controls

Periodontitis

Turkey
Damascus University

Completed

Evaluation of the Levels of Pain and Discomfort and Periodontal Status Between Two Acceleration Methods of Upper Anterior Teeth Retraction

Class II Malocclusion

Syrian Arab Republic
Mundipharma Research Limited

Active, not recruiting

Study of Tinostamustine, First-in-Class Alkylating HDACi Fusion Molecule, in Relapsed/Refractory Hematologic Malignancies

Multiple Myeloma | Hodgkin's Lymphoma | Hematological Malignancies | Cutaneous T Cell Lymphoma

France, United States, Netherlands, Spain, Switzerland, Germany, Italy
Academic and Community Cancer Research United
National Cancer Institute (NCI)

Active, not recruiting

Doxorubicin, Vinblastine, Dacarbazine, Brentuximab Vedotin, and Nivolumab in Treating Patients With Stage I-II Hodgkin Lymphoma

Classic Hodgkin Lymphoma | Ann Arbor Stage IB Hodgkin Lymphoma | Ann Arbor Stage II Hodgkin Lymphoma | Ann Arbor Stage IIA Hodgkin Lymphoma | Ann Arbor Stage IIB Hodgkin Lymphoma | Ann Arbor Stage I Hodgkin Lymphoma | Ann Arbor Stage IA Hodgkin Lymphoma

United States
University of California, San Francisco

Completed

Trial of Bilateral Sagittal Split Osteotomy Induced Paresthesia Using Ultrasonic vs. Reciprocating Saw Instrumentation

Paresthesia | Nerve Injury | Fracture | Surgical Complication | Mandibular Hypoplasia | Mandibular Nerve Injuries | Mandibular Retrognathism | Mandibular Prognathism | Nerve Entrapments | Mandibular Hyperplasia

United States
Mansoura University

Completed

A 2-year Clinical Impact of Bulk-fill Low-viscosity Resin Composite Liners in Class II Restorations.

Dental Caries Class II

Egypt
University of Cologne

Active, not recruiting

Nivolumab and AVD in Early-stage Unfavorable Classical Hodgkin Lymphoma (NIVAHL)

Classical Hodgkin Lymphoma

Germany
3M

Completed

Clinical Performance of Incremental and Bulk Fill Composites in Class II Restorations

Dental Caries

United States
University of Nebraska
National Institute of Nursing Research (NINR)

Completed

Web-Based Weight Loss & Weight Maintenance Intervention for Older Rural Women, Also Known as Women Weigh-in for Wellness

Overweight and Obesity

United States
Ottawa Heart Institute Research Corporation
Canadian Institutes of Health Research (CIHR); Medtronic

Completed

Resynchronization/Defibrillation for Ambulatory Heart Failure Trial (RAFT)

Heart Failure, Congestive

Canada, Netherlands, Australia, Turkey, Denmark, Germany, Belgium
Nuwellis, Inc.

Completed

C-Pulse IDE Feasibility Study- A Heart Assist System

Heart Failure

United States
Al-Azhar University

Active, not recruiting

Evaluation of Two Protocol of Maxillary Protraction in Class III Adolescent After Using (MSE)

Maxillary Protraction in Class III Adolescent After Using (MSE)

Egypt
Gesellschaft fur Medizinische Innovation - Hamatologie...
Amgen

Completed

Validation of a Predictive Model of Response to Romiplostim in Patients With IPSS Low or Intermediate-1 Risk MDS and Thrombocytopenia (EUROPE)

Myelodysplastic Syndromes

France, Germany
Nuwellis, Inc.

Terminated

C-Pulse Implantable Counterpulsation Pump (ICP) - A Heart Assist Device

Heart Failure

Canada
Abbott Medical Devices

Completed

Hemodynamic-GUIDEd Management of Heart Failure (GUIDE-HF)

Heart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure With Reduced Ejection Fraction | Heart Failure NYHA Class IV | Heart Failure With Normal Ejection Fraction | Heart Failure; With Decompensation | Heart Failure...

United States, Canada
Nuwellis, Inc.

Completed

C-Pulse® System European Multicenter Study (OPTIONS-HF)

Heart Failure

Germany, Austria
Fayoum University

Completed

Orthognathic Surgeries and Pharyngeal Airway Space

Mandibular Prognathism

Egypt
3M

Completed

Clinical Study of Filtek™ Bulk Fill Posterior Restorative in Class I and II Restorations

Dental Caries Class II | Dental Caries Class I

China
Brigham and Women's Hospital
Johns Hopkins University; National Institute on Aging (NIA); Rutgers University

Active, not recruiting

Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Semaglutide v DPP4 Inhibitors

Diabetes

United States
H. Lee Moffitt Cancer Center and Research Institute
Bristol-Myers Squibb; National Cancer Institute (NCI); Medarex

Completed

Vaccine Combining Multiple Class I Peptides and Montanide ISA 51VG With Escalating Doses of Anti-PD-1 Antibody Nivolumab or Ipilimumab With Nivolumab For Patients With Resected Stages IIIC/ IV Melanoma

Melanoma (Skin)

United States
Novomics. Co., Ltd.

Completed

Single Patient Classifier (SPC) Prediction for Stage II and III Advanced Gastric Cancer (SPRINT)

Gastric Cancer

Korea, Republic of
Novartis Pharmaceuticals

Completed

Phase Ib/II Study of INC280 + PDR001 or PDR001 Single Agent in Advanced HCC

Advanced Hepatocellular Carcinoma

Taiwan, Canada, Italy, Korea, Republic of, Hong Kong, Germany, China, France
Damascus University

Completed

Patient Outcomes Associated With Two Accelerated Method of Retraction of Upper Front Teeth

Class II Division 1 Malocclusion

Syrian Arab Republic
University of Pennsylvania
Amgen

Enrolling by invitation

Early Metabolic Adaptations to SGLT2 Inhibition in Heart Failure (EMAS-HF)

Heart Failure | Heart Failure NYHA Class II | Heart Failure NYHA Class III

United States
Bayer

Completed

Open-label, Uncontrolled Phase II Trial of Intravenous PI3K Inhibitor BAY80-6946 in Patients With Relapsed, Indolent or Aggressive Non-Hodgkin's Lymphomas

Lymphoma, Non-Hodgkin

Belgium, France, Spain, Hong Kong, Turkey, Russian Federation, Singapore, United States, Canada, Germany, Australia, New Zealand, Finland, Austria, United Kingdom, Bulgaria, Hungary, Italy, Israel, Korea, Republic of, Poland, Port... and more
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

Vaccine Therapy Using Melanoma Peptides for Cytotoxic T Cells and Helper T Cells in Treating Patients With Metastatic Melanoma

Melanoma (Skin)

United States

Search clinical trials for: Class II

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Israel

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations